loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pharmaceutical Excipients offered by Microlex e.U? Find Sodium Monofluorophosphate to address your drug delivery challenges on PharmaCompass.

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    View Presentation

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Monofluorophosphate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 149Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 12Microlex e.U

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Microlex e.U

    MICROLEX® SA-121

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Topical, Oral

    Brand Name : Microlex® SA-121

    Application : Fillers, Diluents & Binders, Lubricants & Glidants

    Excipient Details : It is available in the range of carefully engineered Stearic Acids. Very fine quality of a vegetable Stearic Acid designed for tableting and flowability agent in specific pharmaceutical formulation.

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...

    Technical Specs :

    Ingredient(s) : Stearic Acid

    Dosage Form : Tablet

    Grade : Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Stearic Acid

    Dosage Form : Tablet

    Category : Fillers, Diluents & Binders, Lubricants & Glidants

    Brand : MICROLEX® SA-121

    Applications : It is available in the range of carefully engineered Stearic Acids. Very fine quality of a vegetable Stearic Acid designed for tableting and flowability agent in specific pharmaceutical formulation.

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/JPE

    Technical Specs : Not Available

    Grade : Topical, Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Microlex e.U

    MICROLEX® SA-122

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    03

    Microlex e.U

    MICROLEX® CMC M

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    04

    Microlex e.U

    MICROLEX® CMC L

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    05

    Microlex e.U

    MICROLEX® CMC H

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    06

    Microlex e.U

    MICROLEX® MCC 101

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    07

    Microlex e.U

    MICROLEX® MCC 102

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® MCC 102

    Application : Direct Compression

    Excipient Details : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression

    Brand : MICROLEX® MCC 102

    Applications : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Microlex e.U

    MICROLEX® PVD K30

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® PVD K30

    Application : Solubilizers

    Excipient Details : It is among the most commonly used solid dispersion carrires to solubilize poorly soluble drugs, It can stabilize amorphous drugs in polymer dispersions and maintain supersaturation of API, aqueous solutions by preventing precipitation/cryst...

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Also Available as Microlex® PVD K90.

    Ingredient(s) : Povidone

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Povidone

    Dosage Form : Tablet

    Category : Solubilizers

    Brand : MICROLEX® PVD K30

    Applications : It is among the most commonly used solid dispersion carrires to solubilize poorly soluble drugs, It can stabilize amorphous drugs in polymer dispersions and maintain supersaturation of API, aqueous solutions by preventing precipitation/crystallization

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Also Available as Microlex® PVD K90.

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    09

    Microlex e.U

    MICROLEX® C.PVD S600

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    10

    Microlex e.U

    MICROLEX® SE 80

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Cream / Lotion / Ointment

    Grade : Topical, Oral

    Brand Name : Microlex® SE 80

    Application : Emulsifying Agents, Surfactant & Foaming Agents

    Excipient Details : They are used as surfactants or emulsifying agents in the preparation of emulsions, creams, and ointments for pharmaceutical and cosmetic use. Sorbitan esters and their ethoxylates are a range of mild nonionic surfactants with multifunctional be...

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, FDA...

    Technical Specs :

    Ingredient(s) : sorbitan oleate

    Dosage Form : Cream / Lotion / Ointment

    Grade : Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : sorbitan oleate

    Dosage Form : Cream / Lotion / Ointment

    Category : Emulsifying Agents, Surfactant & Foaming Agents

    Brand : MICROLEX® SE 80

    Applications : They are used as surfactants or emulsifying agents in the preparation of emulsions, creams, and ointments for pharmaceutical and cosmetic use. Sorbitan esters and their ethoxylates are a range of mild nonionic surfactants with multifunctional benefits in

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, FDA IIG

    Technical Specs : Not Available

    Grade : Topical, Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    11

    Microlex e.U

    MICROLEX® PCL-INJ 500

    arrow
    Peptide-Based Therapeutics Summit
    Not Confirmed